glp-1 gastric stasis lawsuit in west virginia semaglutide Wegovy Lawsuit-logopeda-ciaston.pl The world's largest study on

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems

After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more

Monitoring blood glucose is essential

Arrowhead Health offers doctor-guided semaglutide injections for safe, effective weight loss

At least, some derivatives of berberine may